Orthopaedics — Selling, general and administrative expenses
Stryker Orthopaedics — Selling, general and administrative expenses decreased by 0.1% to $742.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.4%, from $760.00M to $742.00M. Over 2 years (FY 2022 to FY 2024), Orthopaedics — Selling, general and administrative expenses shows an upward trend with a 9.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A decrease relative to revenue suggests improved operational efficiency, while an increase may indicate higher sales investment or administrative bloat.
Detailed definition
This captures the overhead costs associated with selling, marketing, and managing the Orthopaedics business segment. It...
Peer comparison
Standard SG&A reporting for business segments in the medical device industry.
syk_segment_orthopaedics_selling_general_and_administrative_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $652.00M | $652.00M | $652.00M | $652.00M | $730.50M | $730.50M | $730.50M | $730.50M | $751.00M | $756.00M | $760.00M | $844.00M | $847.00M | $743.00M | $742.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +12.0% | +0.0% | +0.0% | +0.0% | +2.8% | +0.7% | +0.5% | +11.1% | +0.4% | -12.3% | -0.1% |
| YoY Change | — | — | — | — | +12.0% | +12.0% | +12.0% | +12.0% | +2.8% | +3.5% | +4.0% | +15.5% | +12.8% | -1.7% | -2.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's orthopaedics — selling, general and administrative expenses?
- Stryker (SYK) reported orthopaedics — selling, general and administrative expenses of $742.00M in Q3 2025.
- How has Stryker's orthopaedics — selling, general and administrative expenses changed year-over-year?
- Stryker's orthopaedics — selling, general and administrative expenses decreased by 2.4% year-over-year, from $760.00M to $742.00M.
- What is the long-term trend for Stryker's orthopaedics — selling, general and administrative expenses?
- Over 2 years (2022 to 2024), Stryker's orthopaedics — selling, general and administrative expenses has grown at a 9.2% compound annual growth rate (CAGR), from $2.61B to $3.11B.
- What does orthopaedics — selling, general and administrative expenses mean?
- The operational costs of selling and managing the orthopedic business segment.